TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/25/2024
Back to search
Official data from USPTO
KRAZATI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/25/2024
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
08/09/2022
Registration date
04/11/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/13/2022
First use in commerce
12/13/2022
Drawing code
5
Owner type
03
Owner location
San Diego, CA
Examiner
SINGLETON, RUDY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "KRAZATI", with the "K" in white and green and the remaining letters in white, all on a blue background in gradient from a darker blue at the left to a lighter blue toward the right.
Holders and representatives
Holders
Mirati Therapeutics, Inc.
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
19 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/04/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/30/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/30/2023
IUAF
USE AMENDMENT FILED
12/30/2022
EISU
TEAS STATEMENT OF USE RECEIVED
12/30/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2022
PUBO
PUBLISHED FOR OPPOSITION
11/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/29/2022
DOCK
ASSIGNED TO EXAMINER
09/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2022
NWAP
NEW APPLICATION ENTERED
08/12/2022
Continuous trademark protection
Get notified about every new filing that threatens KRAZATI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.